Search Results - "Dobrusin, E M"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Structure-Based Design of a Potent, Selective, and Irreversible Inhibitor of the Catalytic Domain of the erbB Receptor Subfamily of Protein Tyrosine Kinases by Singh, Juswinder, Dobrusin, Ellen M, Fry, David W, Haske, Taraneh, Whitty, Adrian, McNamara, Dennis J

    Published in Journal of medicinal chemistry (28-03-1997)
    “…We report the use of structure-based drug design to create a selective erbB-1 (a.k.a. epidermal growth factor receptor) and erbB-2 (a.k.a. neu/her2 growth…”
    Get full text
    Journal Article
  2. 2

    Substrate Specificity of the Protein Tyrosine Phosphatases by Zhang, Zhong-Yin, Thieme-Sefler, Andrea M., Maclean, Derek, McNamara, Dennis J., Dobrusin, Ellen M., Sawyer, Tomi K., Dixon, Jack E.

    “…The substrate specificity of a recombinant protein tyrosine phosphatase (PTPase) was probed using synthetic phosphotyrosine-containing peptides corresponding…”
    Get full text
    Journal Article
  3. 3

    Sequence specificity in recognition of the epidermal growth factor receptor by protein tyrosine phosphatase 1B by Milarski, K L, Zhu, G, Pearl, C G, McNamara, D J, Dobrusin, E M, MacLean, D, Thieme-Sefler, A, Zhang, Z Y, Sawyer, T, Decker, S J

    Published in The Journal of biological chemistry (05-11-1993)
    “…Protein tyrosine phosphatases all contain a conserved cysteine that forms an intermediate thiophosphate ester bond during tyrosine phosphate hydrolysis. A…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Determinants of Substrate Recognition in the Protein-tyrosine Phosphatase, PTP1 (∗) by Zhang, Zhong-Yin, Walsh, Amy B., Wu, Li, McNamara, Dennis J., Dobrusin, Ellen M., Miller, W. Todd

    Published in The Journal of biological chemistry (08-03-1996)
    “…Photoaffinity labeling has been used to identify amino acids involved in recognition of protein substrates by the protein-tyrosine phosphatase PTP1. The…”
    Get full text
    Journal Article
  7. 7

    Identification of amino acids in the N-terminal SH2 domain of phospholipase C gamma 1 important in the interaction with epidermal growth factor receptor by Gergel, J R, McNamara, D J, Dobrusin, E M, Zhu, G, Saltiel, A R, Miller, W T

    Published in Biochemistry (Easton) (13-12-1994)
    “…Photoaffinity labeling and site-directed mutagenesis have been used to identify amino acid residues of the phospholipase C gamma 1 (PLC gamma 1) N-terminal SH2…”
    Get full text
    Journal Article
  8. 8

    Tyrosine Kinase Inhibitors. 3. Structure-Activity Relationships for Inhibition of Protein Tyrosine Kinases by Nuclear-Substituted Derivatives of 2,2'-Dithiobis(1-methyl-N-phenyl-1H-indole-3-carboxamide) by Rewcastle, Gordon W, Palmer, Brian D, Dobrusin, Ellen M, Fry, David W, Kraker, Alan J, Denny, William A

    Published in Journal of medicinal chemistry (01-06-1994)
    “…A series of indole-substituted 2,2'-dithiobis(1-methyl-N-phenyl-1H-indole-3-carboxamides) were prepared and evaluated for their ability to inhibit the tyrosine…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Differentiation of peptide molecular recognition by phospholipase Cγ‐1 Src homology‐2 domain and a mutant Tyr phosphatase PTP1bC215S by Maclean, Derek, Sefler, Andrea M., Zhu, Guochang, Decker, Stuart J., Saltiel, Alan R., Singh, Juswinder, Mcnamara, Dennis, Dobrusin, Ellen M., Sawyer, Tomi K.

    Published in Protein science (01-01-1995)
    “…Activated epidermal growth factor receptor (EGFR) undergoes autophosphorylation on several cytoplasmic tyrosine residues, which may then associate with the src…”
    Get full text
    Journal Article
  11. 11

    Design of a potent peptide inhibitor of the epidermal growth factor receptor tyrosine kinase utilizing sequences based on the natural phosphorylation sites of phospholipase C-gamma 1 by Fry, D W, McMichael, A, Singh, J, Dobrusin, E M, McNamara, D J

    Published in Peptides (New York, N.Y. : 1980) (1994)
    “…Peptides that possess primary sequences identical to segments surrounding the natural phosphorylation sites of phospholipase C-gamma 1 (i.e., tyrosines 472,…”
    Get more information
    Journal Article
  12. 12

    Pyrido[2,3-d]pyrimidin-7-ones as Specific Inhibitors of Cyclin-Dependent Kinase 4 by VanderWel, Scott N, Harvey, Patricia J, McNamara, Dennis J, Repine, Joseph T, Keller, Paul R, Quin, John, Booth, R. John, Elliott, William L, Dobrusin, Ellen M, Fry, David W, Toogood, Peter L

    Published in Journal of medicinal chemistry (07-04-2005)
    “…Inhibition of the cell cycle kinase, cyclin-dependent kinase-4 (Cdk4), is expected to provide an effective method for the treatment of proliferative diseases…”
    Get full text
    Journal Article
  13. 13

    Structure–activity relationships for 2-anilino-6-phenylpyrido[2,3- d]pyrimidin-7(8 H)-ones as inhibitors of the cellular checkpoint kinase Wee1 by Palmer, Brian D., Smaill, Jeff B., Rewcastle, Gordon W., Dobrusin, Ellen M., Kraker, Alan, Moore, Charles W., Steinkampf, Randall W., Denny, William A.

    Published in Bioorganic & medicinal chemistry letters (01-04-2005)
    “…2-Anilino-6-phenylpyrido[2,3- d]pyrimidin-7(8 H)-ones are inhibitors of c-Src and Wee1 kinases. Selectivity for c-Src was not markedly changed by 6-phenyl ring…”
    Get full text
    Journal Article
  14. 14

    Inhibition of binding of phospholipase C gamma 1 SH2 domains to phosphorylated epidermal growth factor receptor by phosphorylated peptides by McNamara, D J, Dobrusin, E M, Zhu, G, Decker, S J, Saltiel, A R

    “…A series of tyrosine-containing peptides 1-12: [formula: see text] (six pairs with and without the tyrosine phosphorylated) has been synthesized. The peptides…”
    Get more information
    Journal Article
  15. 15

    2-Aminoquinazoline inhibitors of cyclin-dependent kinases by Bathini, Yadagiri, Singh, Inderjit, Harvey, Patricia J., Keller, Paul R., Singh, Rajeshwar, Micetich, Ronald G., Fry, David W., Dobrusin, Ellen M., Toogood, Peter L.

    Published in Bioorganic & medicinal chemistry letters (01-09-2005)
    “…The inhibition of cyclin-dependent kinase 4 (Cdk4) causes cell cycle arrest and restores a checkpoint that is absent in the majority of tumor cells. Compounds…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18